Price movement over the last 24 hours
Alcon AG vs Stitch Fix Inc — how do they compare? Alcon AG trades at $66.96 (market cap $32.69B), while Stitch Fix Inc trades at $3.57 (market cap $495.68M). The key difference: Alcon AG is far larger — about 65.9× Stitch Fix Inc's market cap, and Alcon AG pays a 0.54% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| ALC | SFIX | |
|---|---|---|
Market Cap | $32.69B | $495.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $92.22 | $5.83 |
52-Week Low | $62.02 | $3.06 |
Enterprise Value | $36.28B | $383.39M |
Dividend Yield | 0.54% | — |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Stitch Fix (SFIX) trades at $3.72, down 3.12% on the day, as the company continues its turnaround efforts with improving financial metrics. The stock shows bearish technical signals but fundamental progress with narrowing losses, a 43.66% gross margin, and three consecutive quarterly earnings beats. Recent news highlights AI-driven personalization initiatives and growing client spending, though the company remains unprofitable with negative cash flow.
The outlook suggests cautious optimism as SFIX stabilizes revenue near $1.3B and reduces net losses. Investment opportunity lies in the discounted valuation (P/S 0.39) and AI growth potential, but risks include persistent unprofitability, competitive pressure, and execution challenges in achieving sustained positive cash flow.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →